Delivery of a Healthy Baby After First-Trimester Maternal Exposure to Lapatinib

Clinical Breast Cancer - Tập 7 - Trang 339-341 - 2006
Hanna Kelly1, Mark Graham2, Elizabeth Humes1, Laneta J. Dorflinger3, Kim A. Boggess4, Bert H. O'Neil1, Jennifer Harris5, Neil L. Spector5, E. Claire Dees1
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
2Waverly Hematology Oncology, Cary, NC
3Institute for Family Health, Family Health International, Research Triangle Park, NC
4Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill
5Department of Discovery Medicine and Clinical Pharmacology, GlaxoSmithKline, Research Triangle Park, NC

Tài liệu tham khảo

Burris, 2005, Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas, J Clin Oncol, 23, 5305, 10.1200/JCO.2005.16.584 Romond Perez Piccart-Gebhart Watson, 2005, Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios, Obstet Gynecol, 105, 642, 10.1097/01.AOG.0000141570.31218.2b Gywn Berry, 1999, Management of breast cancer during pregnancy using a standardized protocol, J Clin Oncol, 17, 855, 10.1200/JCO.1999.17.3.855 Gywn, 2001, Breast cancer during pregnancy, Oncology, 15, 39 Ebert, 1997, Cytotoxic therapy and pregnancy, Pharmacol Ther, 74, 207, 10.1016/S0163-7258(97)82004-9 Gonzalez-Angulo, 2004, Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer, Clin Breast Cancer, 5, 317, 10.3816/CBC.2004.n.037 De Santis, 2000, Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel, Eur J Cancer Care (Engl), 9, 235, 10.1046/j.1365-2354.2000.00231.x Miettinen, 1999, Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure, Nat Genet, 22, 69, 10.1038/8773 Miettinen, 1995, Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor, Nature, 376, 337, 10.1038/376337a0 Yoshimura, 2000, Effect of epidermal growth factor on lung growth in experimental fetal pulmonary hypoplasia, Early Hum Dev, 57, 61, 10.1016/S0378-3782(99)00052-3 Burrows, 1997, Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex, Neuron, 19, 251, 10.1016/S0896-6273(00)80937-X Kee, 1997, Receptor protein tyrosine kinases in perinatal developing rat kidney, Kidney Int, 52, 309, 10.1038/ki.1997.336 Evian-Brion, 1994, Epidermal growth factor receptor and human fetoplacental development, J Pediatr Endocrinol, 7, 295 Lee, 1995, Requirement for neuregulin receptor erbB2 in neural and cardiac development, Nature, 378, 394, 10.1038/378394a0 Trussell, 2004, Contraceptive failure in the United States, Contraception, 74, 89, 10.1016/j.contraception.2004.03.009 Park, 2004, EGF-like growth factors as mediators of LH action in the ovulatory follicle, Science, 303, 682, 10.1126/science.1092463 Ashkenazi, 2005, Epidermal growth factor family members: endogenous mediators of the ovulatory response, Endocrinology, 146, 77, 10.1210/en.2004-0588 Conti, 2006, Role of the epidermal growth factor network in ovarian follicles, Mol Endocrinol, 20, 715, 10.1210/me.2005-0185 Ni, 2004, Application of a gene vaccine targeting HER-2/neu in immunocontraception, DNA Cell Biol, 23, 807, 10.1089/dna.2004.23.807